RP Research Scientist Spotlight: Ömer Karadağ, MD
As a professor at Hacettepe University, a leading university in Turkey, Dr. Ömer Karadağ is well-versed in relapsing polychondritis (RP) and is a crucial part of our international group of supporters.
RP Research Scientist Spotlight: Ora B. Gewurz-Singer, MD
Dr. Singer is a physician scientist at the University of Michigan in Ann Arbor. As a rheumatology specialist with a practice that includes RP patients, she is an excellent advocate and we are grateful for her support.
RP Research Scientist Spotlight: Keith A. Sikora, MD
Working with the National Institutes of Health as a pediatric rheumatologist, Dr. Keith A. Sikora gets to see every pediatric patient with RP who walks through the NIH clinic doors. He’s truly on the front lines when it comes to relapsing polychondritis.
RP Research Scientist Spotlight: Jun Shimizu, MD, PhD
Meet Dr. Jun Shimuzu, MD, PhD, who specializes in internal medicine and immunology at the St. Marianna University School of Medicine. His research focuses on the epidemiology and immunology of RP. In his research, he and his team found that gut microbes are abnormal in patients with RP.
Relapsing Polychondritis Foundation Joins the Vasculitis COVID-19 Patient Project
The Relapsing Polychondritis Foundation, the Vasculitis Foundation (VF), and the Vasculitis Patient Powered Research Network (VPPRN) have teamed up with partners in the Autoimmune Research Collaborative (ARC) to launch a new COVID-19 patient study.
Relapsing Polychondritis Foundation and Race for RP Featured in AHN Autoimmunity Institute Annual Report
We are honored to support the important work being done at the AHN Autoimmunity Institute, which is advancing the diagnosis, treatment, prevention and cure of all autoimmune diseases through collaborative multi-specialty care, cutting-edge research, advocacy and education.
Laurent Arnaud, Relapsing Polychondritis: 2020 highlights
Please watch Dr. Arnaud’s excellent presentation on novelties about the diagnosis and therapeutic management of relapsing polychondritis, from the April 23rd 2020 webinar hosted by ERN ReCONNET.
Relapsing Polychondritis Foundation and Race for RP Support Researchers’ Efforts to Develop Classification Patient-Reported Symptoms Survey
Collecting this data will advance the goal of standardizing definitions of RP to create uniform groups of patients with key shared features for clinical research and may also provide context to aid in diagnosis.
Race for RP and the Relapsing Polychondritis Foundation Host International RP Research Network Meeting
The RP Foundation and Race for RP were most pleased to facilitate the IRPRN meeting and look forward to supporting future collaborative meetings that benefit the RP and autoimmune disease communities.
Relapsing Polychondritis Foundation Joins Race for RP to Sponsor Friends’ Night Out, an Evening Celebrating 35 Years of Hope and Discovery with Friends of Patients at the NIH
The RP Foundation and Race for RP were most pleased to facilitate the IRPRN meeting and look forward to supporting future collaborative meetings that benefit the RP and autoimmune disease communities.
Autoimmunity Symposium at Northern Michigan University Draws Substantial Crowds as Attendees Hear Directly from World-Renowned Experts on Autoimmune Diseases and Relapsing Polychondritis
The half-day event at Reynolds Recital Hall was held on Friday, September 20 and was filled to capacity with standing room only for upwards of 300 people in attendance.
Awareness-Raising on Steroids: Rheumatologists and Researchers in Illinois Help Make a One-in-a-Million Disease, Relapsing Polychondritis, the State’s Top Google Search
Awareness is a goal for most disease-focused organizations, but is especially crucial for the Relapsing Polychondritis Awareness and Support Foundation (RPASF), which highlights a difficult-to-diagnose autoimmune disease that reportedly affects less than one to 3.5 people per million. Making a rare disease part of the public consciousness is a challenging feat, but thanks to RPASF’s advocacy work, […]